Clinical Trial Update: A Study of the Immunogenicity of M. Bovis BCG, Delivered Intradermally in Healthy Volunteers [Phase 1]

View source ↗

Summary

The University of Oxford conducted a Phase 1 study to evaluate the immunogenicity of intradermal Mycobacterium bovis BCG in healthy volunteers. The trial, relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Oxford | Conditions: TB | Phase 1 | Status: COMPLETED